← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3263)
- An enrichment-based approach to interpreting metabolomic data using differential metabolomic profiles within the iDMET framework. (2026/04/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review. (2026/04/25) ♡
- Prognostic value of CALLY index in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy. (2026/04/24) ♡
- Efficacy and Safety of Acupuncture for Pain in Non-Small Cell Lung Cancer: A Meta-Analysis. (2026/04/21) ♡
- Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab. (2026/04/21) ♡
- Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy. (2026/04/21) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of Nutritional Status and Body Composition on Osimertinib Tolerance in Non-Small-Cell Lung Cancer. (2026/04/20) ♡
- A real-world study on the comparative effectiveness of first-line treatment regimens in advanced NSCLC patients with PACC mutations. (2026/04/20) ♡
- Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab. (2026/04/14) ♡
- Association between C-reactive protein-to-albumin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study. (2026/04/11) ♡
- Danggui Buxue Tang, a Traditional Chinese Herbal Formula, Potentiates Paclitaxel Efficacy in Non-Small-Cell Lung Cancer by Inducing Ferroptosis via the Nrf2/GPX4 Axis. (2026/04/10) ♡
- Prognostic nutritional index improved the survival prediction of the revised Tokuhashi and Tomita scores for patients with lung cancer spinal metastases. (2026/04/07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development and validation of an inflammatory-immune-nutritional integrated scoring system: a novel strategy for predicting postoperative survival in non-small cell lung cancer. (2026/04/06) ♡
- Safety evaluation of tarlatamab: A pharmacovigilance study based on the FAERS database. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Artificial Intelligence Assisted (18)F-FDG PET Radiomics in Classifying Histological Subtypes of Lung Cancer: Systematic Review and Meta-analysis. (2026/04/01) ♡
- PFKM promotes chemoresistance in lung adenocarcinoma by regulating RAB8B mediated exosome release. (2026/04/01) ♡
- Exploration of Mechanisms of Keliu Pill on the Inhibition of Lymphangiogenesis in Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation. (2026/04/01) ♡
- AANG: A natural compound formulation for targeting macrophage-myofibroblast transition in non-small-cell lung carcinoma. (2026/04/01) ♡
- Integrating network pharmacology and Mendelian randomization to explore potential targets of Fufang Banmao capsule against non-small cell lung cancer. (2026/04/01) ♡
- [Evidence mapping analysis of clinical studies on Chinese patent medicines for non-small cell lung cancer from past five years]. (2026/04/01) ♡
- Development of ARL4C antisense oligonucleotide with reduced off-target effects and enhanced efficacy as an anti-cancer drug. (2026/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice. (2026/04/01) ♡
- Undetected Weight Loss Associates With Upstaging in Cancer Patients. (2026/04/01) ♡
- Using the Systemic Inflammatory Response Index and the Prognostic Nutritional Index in Predicting Subsequent Bone Metastases in Patients with Non-Small Cell Lung Cancer. (2026/04/01) ♡
- Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria. (2026/04/01) ♡
- Clinical determinants and biomarkers for predicting chemotherapeutic response in advanced non-small cell lung cancer: a single-center retrospective study. (2026/04/01) ♡
- [Buzhong Yiqi Decoction induces ferroptosis of A549/DDP cells to reverse cisplatin resistance in non-small cell lung cancer via AMPK/ACC1 signaling pathway]. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Endocrine Neoplasia Type I. (2026/03/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple Endocrine Neoplasia Type I. (2026/03/28) ♡
- The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients. (2026/03/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Precision-Engineered CD3 T-Cell Engagers for Solid Tumours: Conditional Activation, Microenvironment Modulation, and Clinical Translation. (2026/03/27) ♡
- Integrated pharmacokinetic properties, tissue distribution and metabolism of multiple active constituents in DBD for the treatment of GEM-induced myelosuppression. (2026/03/25) ♡
- Monocyte Preprogramming by Tobacco Carcinogens and Fructose Intake Accelerates Lung Cancer Progression via Metabolic and Epigenetic Pathways. (2026/03/25) ♡
- Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective study. (2026/03/25) ♡
- [Shengmai San improves osimertinib resistance of non-small cell lung cancer cells by regulating the lactate/Wnt/β-catenin/LDHA pathway]. (2026/03/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Medicinal Plant Seeds in Nutritional Oncology: An Integrative Review of Emerging Therapeutics for Non-Small Cell Lung Cancer. (2026/03/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A prospective study on the predictive value of the modified Glasgow prognostic score in non-small cell lung cancer treated with radiation therapy. (2026/03/19) ♡
- Prognostic value of the C-reactive protein-albumin-lymphocyte (CALLY) index in surgically treated non-small cell lung cancer. (2026/03/19) ♡
- The prognostic impact of tryptophan on non-small cell lung cancer survival: insights from plasma essential amino acids. (2026/03/16) ♡
- Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signatures. (2026/03/09) ♡
- Correlation between gut microbiota and their metabolites and the efficacy of chemotherapy combined with immunotherapy for extensive-stage small cell lung cancer. (2026/03/03) ♡
- Treatment patterns, and outcomes in elderly patients with metastatic non-small cell lung cancer: a real-world analysis from a single center in China. (2026/03/02) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC. (2026/03/01) ♡
- Wedge resection versus segmentectomy for older patients with stage IA non-small cell lung cancer. (2026/03/01) ♡
- The role of senescence indicators in the linkage between high-glycemic food intake and lung cancer: a Mendelian randomization study. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hindbrain encephalitis: spectrum of imaging findings: clinical pictorial review. (2026/03/01) ♡
- Whole exome sequencing of lung cancer in Indian patients reveals driver genes and novel mutations with therapeutic potential. (2026/03/01) ♡
- An integrated analysis of network pharmacology and GEO database to decode the active component and the underlying mechanism of Yiwei decoction in non-small cell lung cancer. (2026/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Sex Differences in Cancer Immunotherapy-Clinical Evidence and Mechanisms With a Focus on NSCLC. (2026/03/01) ♡
- Modulatory Effects of Cirsimarin on Lung Cancer A549 Cells Migration in 2D and 3D Cultures Involves Transcriptional Regulation of Metalloproteinases. (2026/03/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.